![Mary Tagliaferri](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mary Tagliaferri
Chief Tech/Sci/R&D Officer at
NEKTAR THERAPEUTICS
Profile
Mary A. Tagliaferri was the founder of Bionovo, Inc., founded in 2002, where the titles held included President, Secretary, Treasurer & Director from 2011 to 2012.
Current jobs include Director at Iambic Therapeutics, Inc. starting in 2024 and Chief Medical Officer at Nektar Therapeutics starting in 2025.
Former jobs include Director at Atossa Therapeutics, Inc., Independent Director at Rayzebio, Inc. from 2021 to 2024, Independent Director at Y-mAbs Therapeutics, Inc. from 2024 to 2025, Independent Director at Enzo Biochem, Inc. from 2023 to 2024, Secretary, Treasurer & Chief Regulatory Officer at Lighten Up Enterprises International, Inc., and Chief Medical Officer at Kanglaite USA, Inc. from 2012 to 2014.
Education includes an undergraduate degree from Cornell University conferred in 1988, a graduate degree from American College of Traditional Chinese Medicine conferred in 1995, and a doctorate from The University of California, San Francisco conferred in 2002.
Mary Tagliaferri active positions
| Companies | Position | Start |
|---|---|---|
| NEKTAR THERAPEUTICS | Chief Tech/Sci/R&D Officer | 2025-08-31 |
Entos, Inc.
 Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Director/Board Member | 2024-09-18 |
Former positions of Mary Tagliaferri
| Companies | Position | End |
|---|---|---|
| YMAS THER | Director/Board Member | 2025-07-10 |
| ENZO BIOCHEM, INC. | Chairman | 2023-10-24 |
| RAYZEBIO, INC. | Director/Board Member | 2024-02-25 |
Kanglaite USA, Inc.
 Kanglaite USA, Inc. Pharmaceuticals: MajorHealth Technology Kanglaite USA, Inc. is a private company based in Redwood City, CA. | Chief Tech/Sci/R&D Officer | 2014-05-31 |
| BIONOVO INC. | Founder | 2012-05-31 |
Training of Mary Tagliaferri
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
86
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
Enzo Biochem, Inc.
 Enzo Biochem, Inc. BiotechnologyHealth Technology Provides enabling life science technologies for research, drug discovery, drug development and diagnostic solutions | Health Technology |
Nektar Therapeutics
 Nektar Therapeutics Pharmaceuticals: MajorHealth Technology Discovers and develops medicines in areas of high unmet medical need | Health Technology |
Lighten Up Enterprises International, Inc.
 Lighten Up Enterprises International, Inc. Financial ConglomeratesFinance Development stage company | Finance |
Bionovo, Inc.
 Bionovo, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals & drugs | Health Technology |
Atossa Therapeutics, Inc.
 Atossa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics and delivery methods for the treatment of breast cancer & other breast conditions | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American College of Traditional Chinese Medicine
 American College of Traditional Chinese Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Y-mAbs Therapeutics, Inc.
 Y-mAbs Therapeutics, Inc. BiotechnologyHealth Technology Develops radioimmunotherapy and antibody-based oncology therapies for treating cancer | Health Technology |
Kanglaite USA, Inc.
Kanglaite USA, Inc. Pharmaceuticals: MajorHealth Technology Kanglaite USA, Inc. is a private company based in Redwood City, CA. | Health Technology |
Rayzebio, Inc.
 Rayzebio, Inc. Pharmaceuticals: MajorHealth Technology Develops radiopharmaceutical therapeutics for cancer treatment | Health Technology |
Entos, Inc.
Entos, Inc. Packaged SoftwareTechnology Services Develops AI driven platform for drug discovery | Technology Services |
- Stock Market
- Insiders
- Mary Tagliaferri
